Strategies to improve γδTCRs engineered T-cell therapies for the treatment of solid malignancies

被引：1
|
作者：
Meringa, A. D. [1 ]
Hernandez-Lopez, P. [1 ]
Cleven, A. [1 ]
de Witte, M. [1 ,2 ]
Straetemans, T. [1 ,2 ]
Kuball, J. [1 ,2 ]
Beringer, D. X. [1 ]
Sebestyen, Z. [1 ]
机构：
[1] Univ Utrecht, Univ Med Ctr Utrecht, Ctr Translat Immunol, Utrecht, Netherlands
[2] Univ Utrecht, Univ Med Ctr Utrecht, Dept Hematol, Utrecht, Netherlands
来源：
FRONTIERS IN IMMUNOLOGY | 2023年 / 14卷
关键词：
T-cell therapy; gamma delta TCR; cancer; immune therapy; antigen; fitness; TME (tumor microenvironment); migration; ANTIGEN RECEPTOR; ANTITUMOR-ACTIVITY; 4-1BB COSTIMULATION; RECOGNITION; LYMPHOCYTES; TUMORS; STRESS; MICROENVIRONMENT; IMMUNOTHERAPY; CYTOKINE;
D O I：
10.3389/fimmu.2023.1159337
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：7
相关论文
共 50 条
  • [1] The Evolution of T-cell Therapies for Solid Malignancies
    Fousek, Kristen
    Ahmed, Nabil
    CLINICAL CANCER RESEARCH, 2015, 21 (15) : 3384 - 3392
  • [2] Targeted therapies in T-cell malignancies
    Anskar Y. H. Leung
    Raymond Liang
    Targeted Oncology, 2007, 2 : 39 - 47
  • [3] Targeted therapies in T-cell malignancies
    Leung, Anskar Y. H.
    Liang, Raymond
    TARGETED ONCOLOGY, 2007, 2 (01) : 39 - 47
  • [4] T-Cell Receptor-Engineered Cells for the Treatment of Hematologic Malignancies
    Nasheed M. Hossain
    Aude G. Chapuis
    Roland B. Walter
    Current Hematologic Malignancy Reports, 2016, 11 : 311 - 317
  • [5] T-Cell Receptor-Engineered Cells for the Treatment of Hematologic Malignancies
    Hossain, Nasheed M.
    Chapuis, Aude G.
    Walter, Roland B.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2016, 11 (04) : 311 - 317
  • [6] Novel Targeted Therapies for T-Cell Malignancies
    Tesio, Melania
    CANCERS, 2022, 14 (16)
  • [7] A Review of CAR T Cells and Adoptive T-Cell Therapies in Lymphoid and Solid Organ Malignancies
    Parums, Dinah V.
    MEDICAL SCIENCE MONITOR, 2025, 31
  • [8] T-cell therapies for EBV-associated malignancies
    Brenner, MK
    Bollard, C
    Huls, MH
    Gottschalk, S
    Heslop, HE
    Rooney, CM
    REGENERATIVE AND CELL THERAPY: CLINICAL ADVANCES, 2005, (11): : 121 - 130
  • [9] Augmenting engineered T-cell strategies in solid cancers through epigenetic priming
    Nielsen, Aaraby Y.
    Ormhoj, Maria
    Traynor, Sofie
    Gjerstorff, Morten F.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2020, 69 (11) : 2169 - 2178
  • [10] Augmenting engineered T-cell strategies in solid cancers through epigenetic priming
    Aaraby Y. Nielsen
    Maria Ormhøj
    Sofie Traynor
    Morten F. Gjerstorff
    Cancer Immunology, Immunotherapy, 2020, 69 : 2169 - 2178
12345